Cost-Utility Analysis of Mycophenolate Mofetil versus Azathioprine Based Regimens for Maintenance Therapy of Proliferative Lupus Nephritis

Figure 1

(a) Markov state transition diagram illustrating the health states and transitions for each treatment strategy for the initial 3 years. The lifetime model consists of the initial 3-year period of maintenance therapy followed by a posttreatment phase as shown in (b). (b) Markov state transition diagram illustrating the health states and transitions for each treatment strategy for the posttreatment phase (after 3 years). LN: lupus nephritis; AZA: azathioprine; MMF: mycophenolate mofetil; IV CYC: intravenous cyclophosphamide; ESRD: end stage renal disease.

(a)

(b)